Skip to main content
. 2020 Oct 17;89(1):42–53. doi: 10.1002/ana.25917

FIGURE 3.

FIGURE 3

Functional outcome at 3 months according to prior anticoagulation treatment in patients with ischemic stroke. The dark gray line indicates a significant association of DOACs (aOR 1.24, 95% CI 1.01–1.51), but not VKA (light gray line, aOR 1.13, 95% CI 0.93–1.38) with good functional outcome (mRS 0–2). aOR = adjusted odds ratio; CI = confidence interval; DOACs = direct oral anticoagulants; mRS = modified Rankin Scale; VKA = vitamin K antagonist.